3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
35
Plasma cell
33
Other hematologic neoplasm
7
Thoracic
1
Sarcoma
1
Myeloid
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
24
Leukemia, Myeloid, Acute
14
Leukemia, Myelomonocytic, Chronic
7
Leukemia
6
Polycythemia Vera
3
Anemia
3
Primary Myelofibrosis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Recurrence
1
Preleukemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neutropenia
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hematologic Diseases
1
GATA2 Deficiency
1
Interventions
fludarabine phosphate
34
Cyclophosphamide
31
Peripheral Blood Stem Cell Transplantation
27
Mycophenolic Acid
25
Cyclosporine
23
Antilymphocyte Serum
23
Busulfan
20
Tacrolimus
17
Radiotherapy
17
Filgrastim
17
Whole-Body Irradiation
15
Methotrexate
15
Methylprednisolone
14
Melphalan
13
Cord Blood Stem Cell Transplantation
12
venetoclax
9
Cytarabine
8
Azacitidine
8
fludarabine
5
Etoposide
5
sargramostim
4
Therapeutics
4
Sirolimus
4
Decitabine
4
Clofarabine
4
Alemtuzumab
4
thymoglobulin
3
nilotinib
3
merphos
2
Voriconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Lenalidomide
×
Myeloid
×
Clear all
NCT04036448
2025-03-11
RevlimidPMS
Celgene
Completed
28 enrolled